Bursitis
📧 Sign up to get email alerts when something new happens for Bursitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-01-08Clinical Trial Update: Efficacy and Safety of Etoricoxib/Betamethasone Combination in Acute Bursitis, Tendinitis and Synovitis [Phase 3]
A Phase 3 trial evaluated the efficacy and safety of an etoricoxib/betamethasone combination for acute bursitis, tendinitis, and synovitis; …
-
FDA approval · 2025-10-03FDA Approved: NAPROXEN — Original Application (Aurobindo Pharma Limited)
FDA approved Naproxen from Aurobindo Pharma Limited as an original generic application (ANDA 216504). Naproxen is a nonsteroidal anti-inflam…
-
CLINICAL_TRIALS research · 2025-08-01Clinical Trial Update: Analysis of Hyperthermia as an Adjunctive Treatment to Evidence-based Clinical Intervention in Subjects With Bursitis: a Double-blind Randomized Clinical Trial [NA]
A double-blind randomized clinical trial from the University of Malaga evaluating hyperthermia as an adjunct to standard treatment for bursi…
-
FDA approval · 2025-02-24FDA Approved: INDOMETHACIN — Original Application (Amneal Pharmaceuticals NY LLC)
FDA approved Amneal Pharmaceuticals NY LLC's original application for Indomethacin, authorizing a generic version of the NSAID with the same…
-
CLINICAL_TRIALS trial_result · 2023-12-29Clinical Trial Update: Comparison Between Subacromial Ultrasound Guided and Systemic Steroid Injection for Frozen Shoulder [Phase 4]
Phase 4 trial comparing subacromial ultrasound-guided injection versus systemic steroid injection in frozen shoulder has been terminated.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2022-09-06FDA Approved: NAPROXEN SODIUM — Supplemental Application (CVS)
The FDA approved a supplemental application for naproxen sodium sponsored by CVS.
-
CLINICAL_TRIALS trial_result · 2021-01-20Clinical Trial Update: Comparison of Steroid Dosages on the Efficacy of Trochanteric Bursa Injection [NA]
A completed clinical trial comparing different steroid dosages for trochanteric bursa injections in bursitis; results posted.
-
CLINICAL_TRIALS trial_result · 2021-01-20Clinical Trial Update: Comparison of Ultrasound Guided Versus Blind Corticosteroid Injection for Trochanteric Bursitis [NA]
A completed clinical trial comparing ultrasound-guided versus blind corticosteroid injections for trochanteric bursitis (bursitis). Results …
-
FDA approval · 2020-10-28FDA Approved: ALEVE GELCAPS — Supplemental Application (Bayer HealthCare LLC.)
FDA approved a supplemental application to add Aleve GelCaps (naproxen sodium) as a new gelcap dosage form for naproxen sodium, expanding th…
-
FDA approval · 2020-07-28FDA Approved: NAPROXEN — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)
FDA approved a supplemental application for Naproxen from Glenmark Pharmaceuticals to update the labeling for the generic product under the …
-
FDA approval · 2020-03-19FDA Approved: NAPROXEN — Supplemental Application (Aurobindo Pharma Limited)
FDA approves Aurobindo Pharma Limited's supplemental application for naproxen (generic) under ANDA075390. This action constitutes a suppleme…
-
CLINICAL_TRIALS trial_result · 2020-02-19Clinical Trial Update: Ketoprofen Topical Patch 20% in the Treatment of Pain Associated With Shoulder, Elbow or Knee Tendonitis or Bursitis [Phase 3]
Phase 3 trial evaluating a 20% ketoprofen topical patch for pain related to shoulder, elbow, or knee tendonitis or bursitis has completed.
-
FDA approval · 2019-11-15FDA Approved: NAPROXEN — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
The FDA approved a supplemental application for a generic Naproxen product from Hikma Pharmaceuticals USA Inc. This action expands access to…
-
CLINICAL_TRIALS trial_result · 2018-01-16Clinical Trial Update: Safety & Efficacy Study of MRX-7EAT Patch in the Treatment of Pain of the Shoulder [Phase 3]
Phase 3 trial update on the MRX-7EAT Patch for shoulder pain in bursitis and tendonitis has completed.
-
CLINICAL_TRIALS trial_result · 2017-06-08Clinical Trial Update: Local Injection Under US Control in GTPS. [Phase 3]
A Phase 3 trial evaluating a local injection for greater trochanteric pain syndrome has been terminated, with periarthritis and bursitis amo…
-
CLINICAL_TRIALS trial_result · 2016-09-30Clinical Trial Update: MedlinePlus Health Prescriptions: Developing a Pragmatic Approach for Clinic Use [NA]
The study completion update describes a pragmatic, clinic-focused trial of MedlinePlus Health Prescriptions sponsored by the University of M…
-
FDA approval · 2016-05-09FDA Approved: NAPROXEN — Supplemental Application (Zameer Pharmaceuticals LLC)
FDA approved a supplemental application for Naproxen submitted by Zameer Pharmaceuticals LLC.
-
CLINICAL_TRIALS withdrawal · 2015-06-23Clinical Trial Update: Comparison of 2 Doses of Corticosteroid Subacromial Injections for the Treatment of Painful Shoulder [NA]
A clinical trial comparing two doses of corticosteroid subacromial injections for painful shoulder has been withdrawn.
-
FDA approval · 2014-11-02FDA Approved: NAPROXEN — Supplemental Application (Amneal Pharmaceuticals of New York LLC)
FDA approved a supplemental application for Naproxen by Amneal Pharmaceuticals of New York LLC (generic Naproxen).
-
FDA approval · 2014-10-16FDA Approved: INDOCIN — Supplemental Application (Zyla Life Sciences US LLC)
FDA approved a supplemental application for Indocin (indomethacin) submitted by Zyla Life Sciences US LLC.
-
CLINICAL_TRIALS withdrawal · 2013-09-23Clinical Trial Update: Steroid Injection for the Treatment of Greater Trochanteric Pain Syndrome [Phase 4]
Phase 4 trial evaluating steroid injections for bursitis (greater trochanteric pain syndrome) has been withdrawn.
-
FDA approval · 2011-09-19FDA Approved: NAPROXEN — Original Application (Cipla USA Inc.)
FDA approves Cipla USA Inc.'s Naproxen under Original Application, making a generic naproxen product available. It is used to relieve pain a…
-
CLINICAL_TRIALS trial_result · 2010-09-20Clinical Trial Update: Safety and Efficacy of Methylprednisolone Infiltration in Anserine Bursitis Treatment [Phase 2]
A Phase 2 clinical trial evaluating the safety and efficacy of methylprednisolone infiltration for bursitis has completed.
-
FDA approval · 2010-03-17FDA Approved: INDOMETHACIN — Original Application (Fresenius Kabi USA, LLC)
The FDA approved an original NDA for indomethacin from Fresenius Kabi USA, LLC. The approval covers indications for inflammatory and musculo…
-
CLINICAL_TRIALS trial_result · 2008-08-14Clinical Trial Update: Efficacy and Safety of Ketoprofen Topical Patch 20% in the Treatment of Pain Associated With Shoulder, Elbow or Knee Tendonitis or Bursitis [Phase 3]
Phase 3 trial evaluating a 20% ketoprofen topical patch for pain due to tendinitis or bursitis has been terminated.